Efficacy and Safety of Ixekizumab in Patients with Psoriatic Arthritis and Inadequate Response to TNF Inhibitors: 3-Year Follow-Up (SPIRIT-P2) (2021)
https://pubmed.ncbi.nlm.nih.gov/33278016/

A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action (2021)
https://pubmed.ncbi.nlm.nih.gov/33771760/

Comparison of disease activity in patients with ankylosing spondylitis under TNFi or NSAID treatment, is there any difference? An observational study (2021)
https://pubmed.ncbi.nlm.nih.gov/31558361/

Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52 (2020)
https://pubmed.ncbi.nlm.nih.gov/32660977/

Role of HLA-B27 in the comorbidities observed in Axial Spondyloarthritis: Data from COMOSPA (2020)
https://pubmed.ncbi.nlm.nih.gov/32251735/

Social economic costs of ankylosing spondylitis in Spain (2020)
https://pubmed.ncbi.nlm.nih.gov/32662412/

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30621746/

Withdrawal of infliximab therapy in ankylosing spondylitis in persistent clinical remission, results from the REMINEA study (2019)
https://pubmed.ncbi.nlm.nih.gov/30953541/

Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe (2019)
https://pubmed.ncbi.nlm.nih.gov/30426237/

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis (2019)
https://pubmed.ncbi.nlm.nih.gov/30552173/

Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study (2018)
https://pubmed.ncbi.nlm.nih.gov/29893222/

Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis (2018)
https://pubmed.ncbi.nlm.nih.gov/30193774/

Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain (2018)
https://pubmed.ncbi.nlm.nih.gov/29417210/

Switching biological disease-modifying antirheumatic drugs in patients with axial spondyloarthritis: results from a systematic literature review (2017)
https://pubmed.ncbi.nlm.nih.gov/29071119/

Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain (2017)
https://pubmed.ncbi.nlm.nih.gov/28389856/